STOCK TITAN

Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Tandem Diabetes Care, Inc. (TNDM) is set to announce its first quarter 2024 results on May 2, 2024, followed by a conference call and webcast to discuss the financial and operating outcomes. Investors can access the live webcast on the company's Investor Center website and participate in the call using provided dial-in details. An archive of the webcast will be available for 30 days post-event.
Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.

A live webcast of the call will be available on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register.vevent.com/register/BI12c72cd6ea054b01881ba78dd494dcc0) and you will be provided with dial-in details, including a personal pin.

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.

Media Contact:

858-366-6900

media@tandemdiabetes.com

Investor Contact:

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

When will Tandem Diabetes Care (TNDM) release its first quarter 2024 results?

Tandem Diabetes Care (TNDM) plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024.

How can investors access the conference call and webcast for Tandem Diabetes Care (TNDM) first quarter 2024 results?

Investors can access the live webcast on Tandem Diabetes Care's Investor Center website and participate in the call using provided dial-in details.

Will there be an archive of the webcast available for Tandem Diabetes Care (TNDM) first quarter 2024 results?

Yes, an archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website.

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

TNDM Rankings

TNDM Latest News

TNDM Stock Data

2.02B
65.14M
0.75%
114.24%
12.78%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
San Diego